08/31/2015 - 3:31pm

The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.

08/31/2015 - 12:06pm

With Naurex, Allergan potentially expands its development of mental health treatments, as the acquired company’s focus is on developing therapies for brain and nervous system disorders like depression. 

08/28/2015 - 12:44pm

Alvogen on Wednesday announced that it will acquire a portfolio of four pharmaceutical products in the United States from Pfizer.

08/28/2015 - 12:13pm
The transaction, whose details won’t be disclosed, is expected to be completed in the third quarter of 2015.
08/28/2015 - 12:01pm

The Food and Drug Administration has a new diabetes treatment developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co.

08/28/2015 - 11:10am

Amgen announced Friday that the Food and Drug Administration had approved its new cholesterol treatment Repatha (evolocumab) injection.

08/26/2015 - 11:29am

The National Association of Chain Drug Stores has announced the winners of its Total Store Expo Product Showcase. 

08/25/2015 - 1:50pm
According to GlobalData’s report, the market is set to grow from $29.4 billion in 2014 to $47.9 billion by 2020, which represents a compound annual growth rate of 8.5%.
08/25/2015 - 11:11am

The drug can be used in children 1 year of age and older with ITP who have not had a sufficient response to a splenectomy, immunoglobulins or corticosteroids.